MedPath
FDA Approval

LUPKYNIS

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 13, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Voclosporin(7.9 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Aurinia Pharma U.S., Inc.

117485579

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LUPKYNIS

Product Details

NDC Product Code
75626-001
Application Number
NDA213716
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 13, 2023
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
POLYSORBATE 40Inactive
Code: STI11B5A2XClass: IACT
TOCOPHERSOLANInactive
Code: O03S90U1F2Class: IACT
Code: 2PN063X6B1Class: ACTIBQuantity: 7.9 mg in 1 1
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath